That's why I liked the 503b route. Sales in the US can begin and build while waiting on FDA.
There are other markets too of course. Europe and Asia combined are considerably larger than the US market and we only need a tiny market penetration of 1% or less to see some very strong earnings.
That's why I liked the 503b route. Sales in the US can begin and...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.46M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 7400 | 2 |
View Market Depth
| Last trade - 09.27am 26/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |
Day chart unavailable